Trial of an injection to reduce shoulder pain for people with Motor Neurone Disease

Recruiting

• Conditions: Motor Neurone Disease; Neurological - Neurodegenerative diseases

• Registration Number: ACTRN12610000989044
• Lead Sponsor: Repatriation General Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-11-16
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

All patients with MND and shoulder pain will be considered for the study.

Exclusion Criteria

Exclusion criteria will include those patients with an expected life span less than the anticipated follow up period (12 weeks) and/or those already in significant respiratory distress.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proposed outcome measures include a 100 point visual analogue pain scale (VAS).In order to achieve a clinically and statistically significant difference between the two groups, a 10 point difference is required on the VAS.[Baseline, 1 week, 6 weeks, 12 weeks.];The shoulder pain and disability index (SPADI) .[Baseline, 1 week, 6 weeks, 12 weeks.]

Secondary Outcome Measures

Name	Time	Method
il[Nil]